Professor, Internal Medicine, University of Michigan Medical School
Endocrinology
Dr. Charles F. Burant, MD
|
|
Give Review
Doctor Charles F. Burant, MD works in the field of Endocrinology. He researched medicine at Medical University of South Carolina College of Medicine. He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Dr. Charles F. Burant is also a published MD. He has 101 publication published. The most recent publication is: The small intestinal fructose transporters: site of dietary perception and evidence for diurnal and fructose sensitive control elements. He accepts all Medicare patients.
Publications
- Maximal Oxidative Capacity during Exercise Is Associated With Skeletal Muscle Fuel Selection and Dynamic Changes in Mitochondrial Protein Acetylation.
- Android Adiposity and Lack of Moderate and Vigorous Physical Activity Are Associated With Insulin Resistance and Diabetes in Aging Adults.
- Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes.
- Metabolic network motifs can provide novel insights into evolution: The evolutionary origin of Eukaryotic organelles as a case study.
- Continuous 24-hour leptin, proopiomelanocortin, and amino Acid measurements in human cerebrospinal fluid: correlations With plasma leptin, soluble leptin receptor, and...
- Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid Metabolism.
- MetDisease - connecting metabolites to Diseases via literature.
- Increased Glucose Metabolism and Glycerolipid Formation by Fatty Acids and GPR40 Underlies the Fatty Acid Potentiation of Insulin Secretion.
- The impact of a managed care Obesity intervention on clinical outcomes and costs: A prospective observational study.
- The impact of weight loss on health-related quality-of-life: implications for cost-effectiveness analyses.
- CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation.
- Network motifs provide signatures that characterize Metabolism.
- Metabolome Response to Glucose in the ?-cell line INS-1 832/13.
- Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy.
- Association of plasma omega-3 and omega-6 lipids With burden of disease measures in bipolar subjects.
- Impulsivity and inhibitory control deficits are associated With unhealthy eating in young adults.
- Alterations in Lipid Signaling Underlie Lipodystrophy Secondary to AGPAT2 Mutations.
- TAK-875 versus placebo or glimepiride in type 2 Diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.
- Fats and factors: lipid profiles associate With personality factors and suicidal history in bipolar subjects.
- Metscape 2 Bioinformatics Tool for the Analysis and Visualization of Metabolomics and Gene Expression Data.
- Intrinsic Aerobic Capacity Sets a Divide for Aging and Longevity.
- Proteomic analysis reveals perturbed energy Metabolism and elevated oxidative stress in hearts of rats with inborn low aerobic capacity.
- PPAR-? action: it's all in your head.
- Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics.
- Integrated metabolome and transcriptome analysis of the NCI60 dataset.
- Skeletal muscle gene expression in response to resistance exercise: sex specific regulation.
- Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.
- A role for 1-acylglycerol-3-phosphate-O-acyltransferase-1 in myoblast differentiation.
- Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks.
- NAD+ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity.
- Identification of Isn1 and Sdt1 as glucose- and vitamin-regulated nicotinamide mononucleotide and nicotinic acid mononucleotide corrected 5''-nucleotidases responsible...
- Improved insulin sensitivity after weight loss and exercise training is mediated by a reduction in plasma fatty acid mobilization, not enhanced oxidative capacity.
- Two bouts of exercise before meals, but not after meals, lower fasting blood glucose.
- Appetite responds to changes in meal content, whereas ghrelin, leptin, and insulin track changes in energy availability.
- Conditional ablation and recovery of forebrain neurogenesis in the mouse.
- Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury.
- Leptin and insulin resistance: good, bad, or still unclear?
- Capillary LC-MS for high sensitivity metabolomic analysis of single islets of Langerhans.
- The rapidly expanding family of adipokines.
- Role of FoxO1 in FFA-induced oxidative stress in adipocytes.
- Total pancreatectomy: indications, operative technique, and postoperative sequelae.
- Identification of pancreatic cancer stem cells.
- Wnt10b inhibits Obesity in ob/ob and agouti mice.
- Islet hypertrophy following pancreatic disruption of Smad4 signaling.
- Islet microvasculature in islet hyperplasia and failure in a model of type 2 Diabetes.
- Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer.
- Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors.
- Exercise energy expenditure is not consciously detected due to oro-gastric, not metabolic, basis of hunger sensation.
- Matrix metalloproteinases contribute to insulin Insufficiency in Zucker diabetic fatty rats.
- Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporter.
- LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function.
- Fickle factor foils fat fate.
- Raf kinase inhibitory protein inhibits beta-cell proliferation.
- DGAT: novel therapeutic target for obesity and type 2 Diabetes mellitus.
- Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet.
- RXR receptor agonist suppression of Thyroid function: central effects in the absence of Thyroid hormone receptor.
- Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.
- Cloning and functional characterization of the mouse fructose transporter, GLUT5.
- Connecting islet development and developing useful islets.
- Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration.
- Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle.
- Calpains play a role in insulin secretion and action.
- Effects of type-2 Diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat.
- Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.
- Alternative splicing of sur2 Exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel.
- Intestinal fructose absorption: clinical and molecular aspects.
- The small intestinal fructose transporters: site of dietary perception and evidence for diurnal and fructose sensitive control elements.
- Congenital hypoThyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site.
- Metabolic effects of troglitazone monotherapy in type 2 Diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
- Troglitazone action is independent of adipose tissue.
- Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid.
- Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment With metformin or troglitazone.
- Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels.
- Hexose transporter expression in rat small intestine: effect of diet on diurnal variations.
- GLUT3 glucose transporter isoform in rat testis: localization, effect of Diabetes mellitus, and comparison to human testis.
- Expression of a Thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroi...
- Rapid reversible substrate regulation of fructose transporter expression in rat small intestine and kidney.
- Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48.
- Small intestine hexose transport in experimental Diabetes. Increased transporter mRNA and protein expression in enterocytes.
- Structure and function of mammalian facilitative sugar transporters.
- Molecular cloning of an apolipoprotein B messenger RNA editing protein.
- Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5.
- Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins.
- Fructose transporter in human spermatozoa and small intestine is GLUT5.
- Human intestinal glucose transporter expression and localization of GLUT5.
- Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by...
- Facilitative glucose transport proteins: structure and regulation of expression in adipose tissue.
- Mammalian glucose transporters: structure and molecular regulation.
- Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestin...
- Molecular biology of mammalian glucose transporters.
- Differential binding of monoiodinated insulins to muscle and liver derived receptors and activation of the receptor kinase.
- Minimal effects of phorbol esters on glucose transport and insulin sensitivity of rat skeletal muscle.
- Tissue specific differences in the insulin receptor kinase activated in vitro and in vivo.
- Comparison of insulin and insulin-like growth factor I receptors from rat skeletal muscle and L-6 myocytes.
- Structural differences between liver- and muscle-derived insulin receptors in rats.
- In vitro and in vivo activation of the insulin receptor kinase in control and denervated skeletal muscle.
- Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle.
- Insulin resistance of denervated rat muscle: a model for impaired receptor-function coupling.
- Phosphorylation of insulin receptors solubilized from rat skeletal muscle.
- Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model.
Schools
Medical University of South Carolina
University of Chicago
Conditions Treated
- Abnormal Thyroid
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Cushing's Syndrome
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Health Alliance
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- NGS CoreSource
- PHP-Physicians Health Plan
- Priority PPO
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
UCSF -
Medical University of South Carolina College of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1437231966 | |
| NPPES Provider LastName | BURANT | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 48105 | |
| NPPES Provider State | MI | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 589.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1437231966 |
| Last Name Of The Provider | BURANT |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Peter Arvan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew T. Kraftson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Lash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Urbanic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vivian H. Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Liselle Douyon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary D. Hammer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ariel L. Barkan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer A. Wyckoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tae-Hwa Chun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria Papaleontiou, MD
This Doctor is OpenDoctor Recommended.
|